Gefitinib in recurrent non-small-cell lung cancer: An IDEAL trial?

Research output: Contribution to journalEditorialpeer-review

38 Scopus citations

Fingerprint Dive into the research topics of 'Gefitinib in recurrent non-small-cell lung cancer: An IDEAL trial?'. Together they form a unique fingerprint.